Jennifer L Good Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Jennifer L Good is Director of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,000 shares of RYTM, which is worth approximately $147,300. The most recent transaction as insider was on Sep 17, 2024, when has been sold 31,751 shares (Common Stock) at a price of $52.4 per share, resulting in proceeds of $1,663,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K

0% 3M change

n/a 12M change

Total Value Held $147,300

JENNIFER L GOOD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 17 2024	SELL Open market or private sale	$1,663,752 $52.4 p/Share	31,751 Reduced 91.37%	3,000 Common Stock
Sep 17 2024	BUY Exercise of conversion of derivative security	$669,946 $21.1 p/Share	31,751 Added 47.74%	34,751 Common Stock
Sep 09 2024	SELL Open market or private sale	$1,878,808 $50.45 p/Share	37,241 Reduced 92.54%	3,000 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$627,883 $16.86 p/Share	37,241 Added 48.06%	40,241 Common Stock
Aug 26 2024	SELL Open market or private sale	$725,545 $50.01 p/Share	14,508 Reduced 82.86%	3,000 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$244,604 $16.86 p/Share	14,508 Added 45.31%	17,508 Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	-	3,000 Added 50.0%	3,000 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare

President & CEO

JLG

Jennifer L Good

Director

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account